Bliss GVS Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.08 | 0.10 | 0.11 | 0.13 | 0.13 |
Long Term Debt-Equity Ratio | 0.05 | 0.04 | 0.04 | 0.05 | 0.05 |
Current Ratio | 5.00 | 4.09 | 4.07 | 4.55 | 5.18 |
Fixed Assets | 1.51 | 1.82 | 2.64 | 2.25 | 2.97 |
Inventory | 7.40 | 7.29 | 7.32 | 6.45 | 7.66 |
Debtors | 1.52 | 1.48 | 1.68 | 1.24 | 1.18 |
Interest Cover Ratio | 20.10 | 12.50 | 30.26 | 22.76 | 19.39 |
PBIDTM (%) | 23.18 | 23.55 | 22.72 | 23.45 | 31.04 |
PBITM (%) | 19.29 | 21.02 | 20.54 | 20.49 | 29.04 |
PBDTM (%) | 22.22 | 21.87 | 22.04 | 22.55 | 29.54 |
CPM (%) | 16.46 | 16.82 | 16.74 | 17.46 | 22.89 |
APATM (%) | 12.57 | 14.29 | 14.56 | 14.50 | 20.89 |
ROCE (%) | 11.19 | 12.81 | 14.59 | 11.71 | 17.64 |
RONW (%) | 7.91 | 9.56 | 11.53 | 9.38 | 14.36 |